Competition and FDI

Recent experience includes:


Assisted this specialist oncology company, headquartered in Cambridge (Massachusetts), with commercial, competition, data protection and employment advice related to its entry into the European market.

Oncologist pharmaceutical company

Advised a specialist oncologist pharmaceutical company on general competition compliance matters (especially, parallel trade and territorial restrictions) as well as preparing its first ever antitrust policy and dawn raid guidelines.

Leading consumer healthcare provider

Advised one of the leading consumer healthcare providers in the world on its proposed acquisition of another direct global competitor.

Competition law risk

Advised a US healthcare company on the competition law risks resulting from the proposed acquisition of another healthcare provider in the UK, respectively two of the largest private providers of in-patient mental healthcare services in the UK; resulting in an extended Phase 1 Competition & Markets Authority merger review with significant divestments.


Advised HC-One, a leading provider of health and social care services in the UK, on the merger control aspects of its acquisition of a portfolio of care homes from Bupa and securing a Phase I clearance from the CMA.


Advised on various licensing agreements with competitors and non-competitors from an EU/UK competition law perspective.

BTG plc

Advised this FTSE 250 specialist pharmaceutical company on a range of multi-jurisdictional merger control issues in respect of M&A transactions.